| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATP binding cassette subfamily A member 4 | 0.493 | 0.769 | 5.3E-48 |
|
disease | 0.110 | None | 0.667 | 3 | 3 | 2010 | 2017 | ||||||||
|
acyl-CoA binding domain containing 5 | 0.931 | 0.192 | 6.1E-03 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
actin gamma 2, smooth muscle | 0.505 | 0.808 | 7.1E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
adenosine deaminase 2 | 0.545 | 0.846 | 8.1E-08 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 20 | 0.760 | 0.385 | 4.5E-38 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 9 | 0.633 | 0.692 | 1.0E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
Abelson helper integration site 1 | 0.513 | 0.846 | 1.1E-25 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
ALX homeobox 1 | 0.636 | 0.462 | 0.18 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ALX homeobox 3 | 0.578 | 0.692 | 1.9E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
APC membrane recruitment protein 1 | 0.570 | 0.654 | 0.85 |
|
disease | 0.400 | strong | 0 | 0 | |||||||||||
|
adhesion molecule with Ig like domain 2 | 0.729 | 0.615 | 0.60 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
AMMECR nuclear protein 1 | 0.659 | 0.692 | 0.82 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ankyrin repeat domain 11 | 0.556 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
anosmin 1 | 0.537 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
archain 1 | 0.705 | 0.462 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
Rho GTPase activating protein 29 | 0.700 | 0.500 | 1.00 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
Rho GTPase activating protein 31 | 0.581 | 0.615 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
AT-rich interaction domain 1B | 0.503 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
AT-rich interaction domain 2 | 0.543 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
AT-rich interaction domain 3B | 0.659 | 0.577 | 0.38 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
aryl hydrocarbon receptor nuclear translocator 2 | 0.599 | 0.731 | 0.99 |
|
disease | 0.100 | None | 0 | 0 |